Year: 2012
Type: review
Abstract: BACKGROUND: Interest in cardiovascular biomarkers in primary prevention has increased dramatically in the past decade. This increase has been fueled by an improved understanding of cardiovascular pathophysiology, as well as novel technologies for biomarker identification. CONTENT: In this review we provide a brief overview of recent concepts in the evaluation of screening biomarkers, because biomarkers may behave differently when used for screening as opposed to diagnosis or disease staging. The following specific biomarker examples are then discussed, with a focus on data from primary prevention studies: high-sensitivity C-reactive protein, B-type natriuretic peptide, lipoprotein-associated phospholipase A2, and high-sensitivity troponin T. The article concludes by addressing novel platforms for biomarker discovery, reviewing recent examples from the field of metabolomics. SUMMARY: An ongoing challenge is to develop screening strategies that can identify individuals at risk for cardiovascular events well before symptoms appear. For this purpose, the measurement of soluble biomarkers could be an important adjunct to traditional cardiovascular risk assessment. Recent studies highlight both the strengths and limitations of "novel" circulating biomarkers, and suggest that substantial work is still needed to identify biomarkers that are sufficiently accurate and cost-effective for routine use in primary prevention.
Source: Clinical Chemistry
Authors: Lauren G Gilstrap, Thomas J Wang
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cardiovascular biomarkers, cardiovascular risk assessment, primary prevention, cardiovascular screening, high-sensitivity C-reactive protein, brain natriuretic peptide, lipoprotein-associated phospholipase A2, high-sensitivity troponin T, metabolomics, circulating biomarkers, cardiovascular risk stratification
Open Access status: bronze
Awards: Nutriuretic Peptides, the Renin-Angiotensin System, and Metabolic Risk in Obesity, Endothelial Progenitor Cells: Clinical Correlates and Prognosis in the Community, Physiologic effects of natriuretic peptide genetic variation, Obesity, salt-sensitivity, and the natriuretic peptides, Metabolomic predictors of insulin resistance and diabetes
OpenAlex ID: W2138834299
